Wire Stories
-
32.6KRadiopharm Theranostics Signs Agreement With NorthStar Medical Radioisotopes for the Supply of Non-Carrier Added (n.c.a.) Actinium-225
SYDNEY & BELOIT, Wis.–(BUSINESS WIRE)–Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses,...
-
35.4KFlashlight Capital Issues Letter to KT&G Shareholders
Intends to Provide Shareholders an Opportunity to Add Independent Directors with Capital Markets Acumen, Operational Expertise and Investor Perspectives to KT&G’s Board...
-
33.6KEnergy Vault Issued Notice of Award From Meadow Creek Solar Farm for a 250MW/500MWh Grid-connected Battery in Victoria, Australia
AEMO Advanced Grid Studies for 500MWh Energy Vault BESS Solution kicks off in Australia First BESS award for short duration storage in...
-
30.8KFidelity D & D Bancorp, Inc. Reports Third Quarter 2022 Financial Results
DUNMORE, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary,�The Fidelity Deposit...
-
31.1KVIQ Solutions Partners with ORdigiNAL Accelerating Channel Distribution of its Innovative Documentation Technology in Europe and Asia Pacific
ORdigiNAL�s vast dealer network to resell VIQ�s NetScribe� and FirstDraft�, powered by aiAssist� to speed documentation of recorded content PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ...
-
32.6KVIQ Solutions Partners with ORdigiNAL Accelerating Channel Distribution of its Innovative Documentation Technology in Europe and Asia Pacific
ORdigiNAL�s vast dealer network to resell VIQ�s NetScribe� and FirstDraft�, powered by aiAssist� to speed documentation of recorded content PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ...
-
33.1KBeiGene Expands Reach of its Innovative BTK Inhibitor with Recent Regulatory Approvals in Latin America
BRUKINSA� received Marketing Authorization as a treatment for rare blood cancers in six countries in Central and South America CAMBRIDGE, Mass., &...
-
36.4K
BeiGene Expands Reach of its Innovative BTK Inhibitor with Recent Regulatory Approvals in Latin America
BRUKINSA� received Marketing Authorization as a treatment for rare blood cancers in six countries in Central and South America CAMBRIDGE, Mass., &...
-
33.1KVIQ Solutions Partners with ORdigiNAL Accelerating Channel Distribution of its Innovative Documentation Technology in Europe and Asia Pacific
ORdigiNAL�s vast dealer network to resell VIQ�s NetScribe� and FirstDraft�, powered by aiAssist� to speed documentation of recorded content PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ...
-
33.0KBeiGene Expands Reach of its Innovative BTK Inhibitor with Recent Regulatory Approvals in Latin America
BRUKINSA� received Marketing Authorization as a treatment for rare blood cancers in six countries in Central and South America CAMBRIDGE, Mass., &...
To Top